ACCOUNT

SECTIONS

HOME
- Homepage
- This Just In
- Chats
- Weather
- Traffic
- Event Guide
- PG Store
- PGe
- Video
- Photos
- The Digs
- RSS Feeds
NEWS
- News Home
- COVID-19
- World
- Nation
- State
- Obituaries
- News Obituaries
- Politics
- Education
- Portfolio
- Science
- Health & Wellness
- Environment
- Aging Edge
- Transportation
- Faith & Religion
- Crimes & Courts
- Social Services
LOCAL
- Local Home
- Region
- City
- North
- East
- West
- South
- Washington
- Westmoreland
- The Neighborhood
- Obituaries
- Classifieds
- Legal Notices
- Real Estate
SPORTS
- Sports Home
- Steelers
- Penguins
- Pirates
- Sports Columns
- Gene Collier
- Ron Cook
- Joe Starkey
- Paul Zeise
- High School Sports
- College Sports
- Pitt
- Penn State
- WVU
- NCAA
- NFL
- MLB
- NBA
- NHL
- North Shore Drive Podcast
OPINION
A&E
- A&E Home
- Celebrities
- Movies
- TV & Radio
- Music
- Concert Listings
- Theatre & Dance
- Art & Architecture
- Books
- Events
LIFE
- Life Home
- Food
- Buying Here
- Homes & Gardens
- Style & Fashion
- Travel
- Restaurants
- Seen
- goodness
- Random Acts of Kindness
- Pets
- Beer Me
- Outdoors
- Holidays
BUSINESS

OTHER

CLASSIFIEDS

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Spero Therapeutics, Inc. - Common Stock (NQ:SPRO)

2.620 +0.010 (+0.38%)

Streaming Delayed Price Updated: 1:27 PM EDT, Apr 7, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	500,679
Open	2.590
Bid (Size)	2.620 (400)
Ask (Size)	2.630 (500)
Prev. Close	2.610
Today's Range	2.480 - 2.665
52wk Range	0.5052 - 3.220
Shares Outstanding	52,571,813
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Spero Therapeutics Inc (NASDAQ:SPRO) Reports Q4 Earnings Beat and Positive Regulatory Step ↗

March 26, 2026

Via Chartmill

Spero Therapeutics Inc (NASDAQ:SPRO) Posts Q3 Revenue and EPS Beat ↗

November 13, 2025

Spero Therapeutics (SPRO) smashed Q3 2025 earnings, with revenue of $5.44M beating $0 estimates and a narrower EPS loss of -$0.13.

Via Chartmill

Performance

YTD	+11.5%	+11.5%
1 Month	+12.9%	+12.9%
3 Month	+7.8%	+7.8%
6 Month	+25.4%	+25.4%
1 Year	+336.8%	+336.8%

More News

Earnings Scheduled For November 13, 2025 ↗

November 13, 2025

Via Benzinga

Insights Ahead: Spero Therapeutics's Quarterly Earnings ↗

November 12, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

August 12, 2025

Via Benzinga

Get insights into the top gainers and losers of Tuesday's after-hours session. ↗

August 12, 2025

Via Chartmill

Earnings Outlook For Spero Therapeutics ↗

August 11, 2025

Via Benzinga

An Overview of Spero Therapeutics's Earnings ↗

May 12, 2025

Via Benzinga

SPERO THERAPEUTICS INC (NASDAQ:SPRO) Reports Mixed Q2 2025 Results with Revenue Beat but Stock Decline ↗

August 12, 2025

Via Chartmill

Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields ↗

June 09, 2025

Via Benzinga

Benzinga Bulls And Bears: Nvidia, Palantir, Marvell Technology — And Markets Rallied In May ↗

May 31, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

May 30, 2025

Via Benzinga

Earnings Scheduled For August 12, 2025 ↗

August 12, 2025

Via Benzinga

Unusual volume stocks in Friday's session ↗

May 30, 2025

Via Chartmill

The trading volume of these stocks is deviating from the norm in today's session. ↗

May 29, 2025

Via Chartmill

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

May 28, 2025

Via Benzinga

These stocks are making the most noise in today's session. ↗

May 28, 2025

Via Chartmill

Small-Cap Movers Under $1: HIT, SPRO, SGN, PRSO, SGBX Drive Momentum Across AI, Biotech, Crypto, Software, Etc.

May 28, 2025

Via AB Newswire

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

May 28, 2025

Via Benzinga

Crude Oil Gains 2%; Macy's Lowers Earnings Forecast ↗

May 28, 2025

Via Benzinga

Why Is GSK Partner Spero Therapeutics Stock Skyrocketing On Wednesday? ↗

May 28, 2025

Via Benzinga

US Stocks Gain; Abercrombie & Fitch Posts Upbeat Earnings ↗

May 28, 2025

Via Benzinga

GSK, Spero Therapeutics Stop Antibiotic Trial For Complicated Urinary Tract Infections Early After Positive Results, Retail’s Thrilled ↗

May 28, 2025

Via Stocktwits

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

May 28, 2025

Via Benzinga

Earnings Scheduled For May 13, 2025 ↗

May 13, 2025

Via Benzinga

Frequently Asked Questions

Is Spero Therapeutics, Inc. - Common Stock publicly traded?

Yes, Spero Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Spero Therapeutics, Inc. - Common Stock trade on?

Spero Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Spero Therapeutics, Inc. - Common Stock?

The ticker symbol for Spero Therapeutics, Inc. - Common Stock is SPRO on the Nasdaq Stock Market

What is the current price of Spero Therapeutics, Inc. - Common Stock?

The current price of Spero Therapeutics, Inc. - Common Stock is 2.620

When was Spero Therapeutics, Inc. - Common Stock last traded?

The last trade of Spero Therapeutics, Inc. - Common Stock was at 04/07/26 01:27 PM ET

What is the market capitalization of Spero Therapeutics, Inc. - Common Stock?

The market capitalization of Spero Therapeutics, Inc. - Common Stock is 137.74M

How many shares of Spero Therapeutics, Inc. - Common Stock are outstanding?

Spero Therapeutics, Inc. - Common Stock has 138M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.